FSTQX | VTABX | FSTQX / VTABX | |
Total Expense Ratio | 0.00 | 0.10 | - |
Annual Report Gross Expense Ratio | 0.01 | 0.10 | 10% |
Fund Existence | 4 years | 12 years | - |
Gain YTD | 0.950 | 1.765 | 54% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.7B | 104B | 13% |
Annual Yield % from dividends | 2.89 | 4.27 | 68% |
Returns for 1 year | 4.95 | 5.84 | 85% |
Returns for 3 years | 9.24 | 12.11 | 76% |
Returns for 5 years | N/A | -1.09 | - |
Returns for 10 years | N/A | 22.91 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JPIVX | 31.13 | 0.11 | +0.35% |
JPMorgan U.S. Applied Data Sci Val I | |||
PRMSX | 37.81 | 0.10 | +0.27% |
T. Rowe Price Emerging Markets Stock | |||
QISCX | 26.35 | 0.05 | +0.19% |
Federated Hermes MDT Small Cap Core IS | |||
VKSEX | 10.11 | -0.01 | -0.10% |
Virtus KAR Small-Mid Cap Value C | |||
FSRKX | 8.74 | -0.01 | -0.11% |
Fidelity Strategic Real Return K6 |